A carregar...
Diclofenac potassium for oral solution (CAMBIA(®)) in the acute management of a migraine attack: clinical evidence and practical experience
Migraine headache affects about 12% of Western populations and is the third most common disease worldwide (sixth in terms of disability). In 1993, triptans were introduced in the United States as a new treatment for managing migraine attacks, but their use is limited by lack of response and safety c...
Na minha lista:
| Publicado no: | Ther Adv Neurol Disord |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5415228/ https://ncbi.nlm.nih.gov/pubmed/28507605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285616684494 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|